Zobrazeno 1 - 10
of 23
pro vyhledávání: '"Xuerui Guo"'
Autor:
Li Wang, Qunyan Yao, Xuerui Guo, Bingmei Wang, Jingyi Si, Xingye Wang, Shisong Jing, Ming Yan, Yan Shi, Guangqi Song, Xizhong Shen, Jiyu Guan, Yicheng Zhao, Changfeng Zhu
Publikováno v:
Journal of Nanobiotechnology, Vol 22, Iss 1, Pp 1-15 (2024)
Abstract Pancreatic cancer, predominantly pancreatic ductal adenocarcinoma (PDAC), remains a highly lethal malignancy with limited therapeutic options and a dismal prognosis. By targeting the underlying molecular abnormalities responsible for PDAC de
Externí odkaz:
https://doaj.org/article/29823b50b96a453db79b7b3416bb8c4e
Autor:
Xuerui Guo, Li Wang, Jinlong Zhang, Quan Liu, Bingmei Wang, Da Liu, Fei Gao, Gongga Lanzi, Yicheng Zhao, Yan Shi
Publikováno v:
npj Biofilms and Microbiomes, Vol 10, Iss 1, Pp 1-15 (2024)
Abstract Limitations in the clinical treatment of Staphylococcus aureus (S. aureus) infections have arisen due to the advent of antibiotic-resistant strains. Given the immense potential of therapeutic strategies targeting bacterial virulence, the rol
Externí odkaz:
https://doaj.org/article/c64ee4fd07ce4bf9a3894eaa50f07119
Autor:
Shisong Jing, Xinran Ren, Li Wang, Xiangri Kong, Xingye Wang, Xiren Chang, Xuerui Guo, Yan Shi, Jiyu Guan, Tiedong Wang, Bingmei Wang, Wu Song, Yicheng Zhao
Publikováno v:
Virulence, Vol 13, Iss 1, Pp 578-588 (2022)
The resistance of Staphylococcus aureus (S. aureus) to various antibiotics has increased dramatically due to the misuse of antibiotics, and thus the development of new anti-infective drugs with new targets is urgently needed to combat resistance. Cas
Externí odkaz:
https://doaj.org/article/1747e8976e09405198bd0aa09f116e80
Autor:
Liyan Sui, Letian Li, Yinghua Zhao, Yicheng Zhao, Pengfei Hao, Xuerui Guo, Wenfang Wang, Guoqing Wang, Chang Li, Quan Liu
Publikováno v:
Signal Transduction and Targeted Therapy, Vol 8, Iss 1, Pp 1-3 (2023)
Externí odkaz:
https://doaj.org/article/793c08b3ebc847dea69c434ba0aa058c
Autor:
Ying Meng, Mengli Jin, Dai Yuan, Yicheng Zhao, Xiangri Kong, Xuerui Guo, Xingye Wang, Juan Hou, Bingmei Wang, Wu Song, Yong Tang
Publikováno v:
Frontiers in Pharmacology, Vol 13 (2022)
Hypopharyngeal squamous cell carcinoma (HSCC) is one of the high mortality cancers with a poor prognosis, which is driving the development of new chemotherapeutic agents. We identified the anticancer effects of a natural compound, solamargine (SM), o
Externí odkaz:
https://doaj.org/article/12720cb49cbf4637823f8bedffbbaa91
Autor:
Xin Jiang, Xiangri Kong, Xingye Wang, Zishu Yu, Xuerui Guo, Mengli Jin, Xiaoyu Chen, Jiyu Guan, Cui Wu, Lin Wei, Chi Zhang, Guangqi Song, Tao Jiang, Li Wang, Yicheng Zhao, Wu Song
Publikováno v:
Journal of Applied Microbiology. 134
Aims The main purpose of this study was to study the therapeutical effect of oroxylin A glucuronide (OAG) on methicillin-resistant Staphylococcus aureus (MRSA). Methods and results By substrate peptide reaction-based fluorescence resonance energy tra
Publikováno v:
Journal of Biotech Research; 2023, Vol. 15, p316-326, 11p
Autor:
Liyan Sui, Letian Li, Yinghua Zhao, Yicheng Zhao, Pengfei Hao, Xuerui Guo, Wenfang Wang, Guoqing Wang, Chang Li, Quan Liu
Publikováno v:
Signal transduction and targeted therapy. 8(1)
Autor:
Wu Song, Li Wang, Yinghua Zhao, Gongga Lanzi, Xingye Wang, Chi Zhang, Jiyu Guan, Wei Wang, Xuerui Guo, Ying Meng, Bingmei Wang, Yicheng Zhao
Publikováno v:
Microbiology spectrum. 10(4)
This study aimed to identify hibifolin as a sortase A (SrtA) inhibitor and to determine whether it could attenuate the virulence of methicillin-resistant Staphylococcus aureus (MRSA). We employed a fluorescence resonance energy transfer (FRET) assay
Autor:
Quan Liu, Heming Wang, He Zhang, Liyan Sui, Letian Li, Wang Xu, Shouwen Du, Pengfei Hao, Yuhang Jiang, Jing Chen, Xiaoyun Qu, Mingyao Tian, Yinghua Zhao, Xuerui Guo, Xingye Wang, Wu Song, Guangqi Song, Zhengkai Wei, Zhijun Hou, Guoqing Wang, Minhua Sun, Xiao Li, Huijun Lu, Xinyu Zhuang, Ningyi Jin, Yicheng Zhao, Chang Li, Ming Liao
Publikováno v:
Proceedings of the National Academy of Sciences of the United States of America. 119(30)
SARS-CoV-2, the causative agent of the COVID-19 pandemic, undergoes continuous evolution, highlighting an urgent need for development of novel antiviral therapies. Here we show a quantitative mass spectrometry-based succinylproteomics analysis of SAR